Board of Directors
Tyler Binney
Tyler Binney brings decades of experience in the MedTech industry, with a proven track record of driving growth through strategic leadership and operational expertise. From April 2021 to March 2025, Tyler served as the CEO of Relievant Medsystems and successfully led its acquisition to Boston Scientific for more than $850 million. Prior to Relievant, Tyler was the President and GM of Teleflex's Interventional Urology business unit. He also served as Vice President of Sales at NeoTract where he played a key role in the company's $1.1 billion acquisition to Teleflex. Tyler currently serves as Chairman of the Board of iO Urology and is a member of the board of directors of SetPoint Medical, Imperative Care, and Intrinsic Therapeutics.